OPKO Health, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles about it in the 4Search index. Click a dot on the chart for the event and the news of that day.
Key statistics
Against its peers
Compare in full ›| OPK.TA | ON4.F | 4564.T | BHVN | IDYA | ORKA | |
|---|---|---|---|---|---|---|
| Market cap | 3.96B | 6.33B | 5.72B | 1.87B | 2.47B | 6.50B |
| P/E (TTM) | — | 15.5 | — | — | — | — |
| Forward P/E | — | — | -0.7 | -8.1 | -6.1 | -33.5 |
| Price/book | 3.6 | 1.3 | 2.8 | -19.1 | 2.3 | 5.4 |
| Dividend yield | — | 3.35% | — | — | — | — |
| 1-year change | +25.63% | +18.35% | −28.57% | +40.87% | −23.01% | +233.12% |
| Today | −1.88% | −0.96% | −6.67% | −9.23% | −2.33% | −1.80% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 20 min.
Latest news
All OPK.TA news ›Wren Laboratories Announces Acquisition of Pure Diagnostic, Unifying Clinical Laboratory Operations Under the Wren Brand
Newswise — Branford, CT — September 2025 — Wren Laboratories LLC, a CLIA-, CAP-, NYSDOH- and ISO-certified molecular diagnostics laboratory and leader in advanced mRNA liquid biopsy technologies, today announced the acquisition of Pure…
OraTek Diagnostics partners with Palmetto InnovaSphere to establish Spartanburg HQ
Business News Startups OraTek Diagnostics partners with Palmetto InnovaSphere to establish Spartanburg HQ Jay King November 12, 2026 iStock photo OraTek Diagnostics, a life sciences company specializing in saliva-based diagnostic…
OPKO Health (NASDAQ:OPK) Stock Falls 4.4% – Here’s Why
Posted by Mitch Edgeman on Nov 11th, 2026 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits OPKO Health, Inc. (NASDAQ:OPK – Get Free Report) shares were down 4.4% during mid-day trading on Wednesday. The stock tra
Ob Hospitalist Group Announces Partnership with Kohlberg & Company
Sep 27, 2021, 16:10 ET Evan Wildstein, Partner of Kohlberg, said, "We are excited to partner with Lenny and the OBHG team to support the Company's best–in–class clinical care. OBHG is well–positioned as the market–leading obstetric…
Lisata Therapeutics Subsidiary Marea Therapeutics Doses First Patient In Phase 2 Clinical Trial Of MAR002 For The Treatment Of Acromegaly
Marea Therapeutics, LLC , a subsidiary of Lisata Therapeutics, Inc. announced the first patient has been dosed in its Phase 2 clinical trial of MAR002 for the treatment of acromegaly. Acromegaly is a... Marea Therapeutics, LLC (Marea), a…
What OPKO Health (OPK) Said on Its Q3 Earnings Call
Posted by Michael Walen on Nov 7th, 2026 OPKO Health (NASDAQ:OPK) reported 16% growth in third-quarter revenue from continuing operations and outlined plans to focus on drug development and pharmaceutical products following its proposed…
More from 1 other outlet
OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026
MIAMI, Oct. 28, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ:OPK), a multinational biopharmaceutical company, today announced that it will report operating and financial results for the third quarter 2026 on Wednesday,…
Opko Health upgraded by Barrington Research with a new price target
Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Opko Health upgraded by Barrington…
OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
MIAMI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that…
Opko sees FY 2026 continuing-ops revenue of $268M-$278M following $722M LabCorp asset sale agreement
OPKO Health Q3 2026 earnings: LabCorp deal reshapes strategy, updates guidance, and highlights biotech pipeline catalysts. Earnings Call Insights: OPKO Health (OPK) Q3 2026 - "The LabCorp transaction marks a defining moment for OPKO. Once…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- quantisnow.com9
- themarketsdaily.com6
- markets.businessinsider.com5
- seekingalpha.com2
- builtin.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 28 articles, not a forecast.